Impact of calcium, phosphate, PTH abnormalities and management on mortality in hemodialysis: Results from the RISCAVID study

201021 citationsJournal Article

Authors

Vincenzo Panichi · Ospedale Versilia

Roberto Bigazzi · Ospedale di Livorno

Sabrina Paoletti · Ospedale Versilia

Emanuela Mantuano · Ospedale di Livorno

Sara Beati · Ospedale Versilia

Valentina Marchetti · Pontifical Lateran University

G. Bernabini ·

Abstract

The RISCAVID study highlights the difficulty of controlling bone mineral metabolism in HD patients and lends support to the hypothesis that a carefully chosen phosphate binder might impact survival in HD patients.

Topics & Keywords

Parathyroid Disorders and Treatments Dialysis and Renal Disease Management Neurological and metabolic disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Nephrology

Volume 23, Issue 5, pp. 556-562

DOI: 10.1093/joneph/23.5.556

Field-Weighted Citation Impact: 1.63